Curing Fibrosis is Our Mission
OUR MISSION
Our mission is to develop and deliver transformative therapies that reverse fibrosis, restore health and improve the lives of patients worldwide.
OUR SCIENCE
Fibrosis affects millions of people, yet today's therapies still cannot fully stop or reverse it.
At Thendor, we are developing medicines with the potential to halt fibrosis and restore healthy tissue function across a wide spectrum of fibrotic diseases.
At Thendor, we are developing medicines with the potential to halt fibrosis and restore healthy tissue function across a wide spectrum of fibrotic diseases.
The Unmet Need in Fibrosis
A widespread disease in urgent need of new solutions
0+
0%
0
0+
AREA OF FIBROTIC DISEASE
Area of Focus
Pulmonary Fibrosis
Developing new treatments to address harmful scarring in the lungs and help preserve breathing function.
Learn More
Urological Fibrosis
Through our subsidiary Thenduro, advancing therapies for fibrotic conditions of the urinary system, where current treatments remain limited.
Learn More
Systemic Fibrotic Diseases
Targeting shared biological pathways that drive fibrosis across multiple organs.
Learn MoreIMPORTANT NOTICE
We are an early stage company developing a research pipeline of products addressing fibrotic diseases. The product candidates described on this website are in various stages of development and have not been approved or determined to be safe or effective by the U.S. Food and Drug Administration or any comparable regulatory authority. Nothing on this website is intended to suggest the safety, efficacy, or commercial availability of any product candidate in the United States.